Ethyol amifostine cytoprotective agent data

In a Phase II trial reported at the American Society of Clinical Oncology meeting in

Read the full 152 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE